66.34
price up icon2.55%   1.65
after-market Handel nachbörslich: 66.34
loading
Schlusskurs vom Vortag:
$64.69
Offen:
$64.25
24-Stunden-Volumen:
495.66K
Relative Volume:
0.67
Marktkapitalisierung:
$3.65B
Einnahmen:
$76.81M
Nettoeinkommen (Verlust:
$-162.42M
KGV:
-22.19
EPS:
-2.99
Netto-Cashflow:
$-122.49M
1W Leistung:
+3.61%
1M Leistung:
+7.12%
6M Leistung:
-15.76%
1J Leistung:
+24.58%
1-Tages-Spanne:
Value
$64.25
$67.83
1-Wochen-Bereich:
Value
$63.13
$67.83
52-Wochen-Spanne:
Value
$47.86
$107.37

Arcellx Inc Stock (ACLX) Company Profile

Name
Firmenname
Arcellx Inc
Name
Telefon
240-327-0603
Name
Adresse
800 BRIDGE PARKWAY, REDWOOD CITY
Name
Mitarbeiter
163
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ACLX's Discussions on Twitter

Vergleichen Sie ACLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ACLX
Arcellx Inc
66.34 3.65B 76.81M -162.42M -122.49M -2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Arcellx Inc Stock (ACLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-08 Eingeleitet Redburn Atlantic Buy
2024-09-03 Eingeleitet Cantor Fitzgerald Overweight
2024-05-31 Eingeleitet Piper Sandler Overweight
2024-03-07 Eingeleitet Morgan Stanley Overweight
2024-01-04 Bestätigt Needham Buy
2023-12-19 Eingeleitet Scotiabank Sector Outperform
2023-10-30 Eingeleitet TD Cowen Outperform
2023-10-17 Eingeleitet UBS Buy
2023-05-18 Eingeleitet Truist Buy
2023-04-14 Eingeleitet Robert W. Baird Outperform
2023-03-14 Eingeleitet Stifel Buy
2023-02-13 Eingeleitet H.C. Wainwright Buy
2022-12-13 Fortgesetzt BofA Securities Buy
2022-10-31 Eingeleitet Guggenheim Buy
2022-10-27 Eingeleitet Needham Buy
2022-07-20 Eingeleitet Canaccord Genuity Buy
2022-03-01 Eingeleitet BofA Securities Buy
2022-03-01 Eingeleitet SVB Leerink Outperform
Alle ansehen

Arcellx Inc Aktie (ACLX) Neueste Nachrichten

pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Cancer Cell Market Exclusive Report with Detailed Study Analysis | Abbott Laboratories, Cellectis, Arcellx, GE - newstrail.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citigroup Initiates Arcellx at Buy With $110 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx initiated with a Buy at Citi - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx (ACLX): Citi Initiates Buy Rating with Promising Outlook | ACLX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Aileen Fernandes | People on The MoveSan Francisco Business Times - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Aileen Fernandes - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito-cel: A Promising Market Entrant with Superior Efficacy and Safety in Multiple Myeloma Treatment - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito Cel Therapy: A Promising Contender in Multiple Myeloma Treatment with Strong Market Potential - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

ACLX: HC Wainwright & Co. Reiterates Buy Rating with $115 Target | ACLX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx stock maintains buy rating at H.C. Wainwright on launch plans - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Strategic Partnership with Kite Enhances Anito-cel Therapy Launch and Market Position - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Promising Potential of Arcellx Inc’s Anito-cel Therapy Drives Buy Rating - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Positive Outlook for Arcellx Inc: Promising Anito-cel Therapy and Strategic Market Positioning - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Promising Market Position and Growth Potential in Multiple Myeloma Therapy - TipRanks

Jun 16, 2025
pulisher
Jun 14, 2025

Rhumbline Advisers Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Transcript : Arcellx, Inc.Special Call - MarketScreener

Jun 13, 2025
pulisher
Jun 12, 2025

(ACLX) Technical Data - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 12, 2025

Arcellx’s SWOT analysis: CAR-T pioneer’s stock poised for myeloma market shake-up - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

arcellx director Kavita Patel sells shares worth $101,040 By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

arcellx director Kavita Patel sells shares worth $101,040 - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for Arcellx FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Two Sigma Investments LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

FY2026 EPS Estimates for Arcellx Lifted by Leerink Partnrs - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Squarepoint Ops LLC Sells 4,670 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Arcellx FY2029 EPS Forecast Raised by Leerink Partnrs - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Kalkine: Top NASDAQ Stocks Arcellx’s Role by Kalkine - Kalkine Media

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Acquires 1,100 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Sells 945 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 03, 2025
pulisher
May 31, 2025

How to Take Advantage of moves in (ACLX) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 29, 2025

Nuveen Asset Management LLC Sells 9,110 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Arcellx Inc Holds Annual Stockholders Meeting - TipRanks

May 28, 2025
pulisher
May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga

May 23, 2025
pulisher
May 22, 2025

Thinking Of Buying Arcellx Inc (NASDAQ: ACLX) Stock? Here’s What You Need To Know - Stocksregister

May 22, 2025
pulisher
May 21, 2025

Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Business Wire

May 21, 2025
pulisher
May 21, 2025

Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Bluefield Daily Telegraph

May 21, 2025
pulisher
May 21, 2025

Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday - Benzinga

May 21, 2025
pulisher
May 20, 2025

Baron Discovery Fund Initiated a Position in Arcellx (ACLX) - Insider Monkey

May 20, 2025
pulisher
May 19, 2025

BNP Paribas Financial Markets Makes New $1.53 Million Investment in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 19, 2025
pulisher
May 16, 2025

Arcellx Inc (ACLX) Receives a Buy from Canaccord Genuity - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Mercer Global Advisors Inc. ADV Takes $278,000 Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 16, 2025
pulisher
May 16, 2025

Arcellx, Inc. Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Arcellx Inc’s Anito-cel Shows Promising Results in Phase 2 Trial, Earning Buy Rating from Analyst - TipRanks

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald Expects Reduced Earnings for Arcellx - Defense World

May 15, 2025
pulisher
May 14, 2025

Insiders At Arcellx Sold US$2.6m In Stock, Alluding To Potential Weakness - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Promising Clinical Data and Strong Safety Profile Lead to Buy Rating for Arcellx Inc’s Anito-cel - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx Inc’s Anito-cel Shows Promising Efficacy and Safety in Multiple Myeloma, Earning Buy Rating - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx's Potential Multiple Myeloma Treatment Shows 97% Overall Response Rate in Phase 2 Study; Shares Rise - marketscreener.com

May 14, 2025

Finanzdaten der Arcellx Inc-Aktie (ACLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Arcellx Inc-Aktie (ACLX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Patel Kavita
Director
Jun 10 '25
Sale
67.36
1,500
101,040
0
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):